These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31799831)

  • 1. DARK Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice/K2).
    Worob A; Wenthur C
    ACS Chem Neurosci; 2020 Dec; 11(23):3881-3892. PubMed ID: 31799831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.
    Davidson C; Opacka-Juffry J; Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E; Molina-Holgado F
    Adv Pharmacol; 2017; 80():135-168. PubMed ID: 28826533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.
    Brents LK; Prather PL
    Drug Metab Rev; 2014 Feb; 46(1):72-85. PubMed ID: 24063277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.
    Alves VL; Gonçalves JL; Aguiar J; Teixeira HM; Câmara JS
    Crit Rev Toxicol; 2020 May; 50(5):359-382. PubMed ID: 32530350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health.
    Bukke VN; Archana M; Villani R; Serviddio G; Cassano T
    Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
    De Luca MA; Fattore L
    Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.
    Seely KA; Lapoint J; Moran JH; Fattore L
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):234-43. PubMed ID: 22561602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic cannabinoids: the dangers of spicing it up.
    Salani DA; Zdanowicz MM
    J Psychosoc Nurs Ment Health Serv; 2015 May; 53(5):36-43. PubMed ID: 25974923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic cannabinoids: the hidden side of Spice drugs.
    Pintori N; Loi B; Mereu M
    Behav Pharmacol; 2017 Sep; 28(6):409-419. PubMed ID: 28692429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Cannabinoids in Prisons: Content Analysis of TikToks.
    McMann TJ; Calac A; Nali M; Cuomo R; Maroulis J; Mackey TK
    JMIR Infodemiology; 2022; 2(1):e37632. PubMed ID: 37113804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ
    Hoffman AF; Lycas MD; Kaczmarzyk JR; Spivak CE; Baumann MH; Lupica CR
    Addict Biol; 2017 Mar; 22(2):390-399. PubMed ID: 26732435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic cannabinoid receptor agonists: classification and nomenclature.
    Potts AJ; Cano C; Thomas SHL; Hill SL
    Clin Toxicol (Phila); 2020 Feb; 58(2):82-98. PubMed ID: 31524007
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthetic Cannabinoids-"Spice" Can Induce a Psychosis: A Brief Review.
    Yeruva RR; Mekala HM; Sidhu M; Lippmann S
    Innov Clin Neurosci; 2019 Jan; 16(1-2):31-32. PubMed ID: 31037226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.
    Chung EY; Cha HJ; Min HK; Yun J
    Arch Pharm Res; 2021 Apr; 44(4):402-413. PubMed ID: 33811300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB).
    Parajuli P; Regmi MR; Lara-Garcia OE; Abu Limon I; Deckard A
    J Community Hosp Intern Med Perspect; 2020 Aug; 10(4):361-364. PubMed ID: 32850099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spice in France: mixed herbs containing synthetic cannabinoids].
    Schlatter J; Chiadmi F; Chariot P
    Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Pot: Not Your Grandfather's Marijuana.
    Ford BM; Tai S; Fantegrossi WE; Prather PL
    Trends Pharmacol Sci; 2017 Mar; 38(3):257-276. PubMed ID: 28162792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.